Cogent Biosciences, Inc. (COGT)

33.38 -1.23 (-3.55%) USD  |  NASDAQ  |  Mar 20, 16:00
33.79 +0.41 (+1.23%) After-Hours: 07:10
More

Cogent Biosciences Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Terns Pharmaceuticals, Inc. Upgrade
Nuvalent, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade